e-learning
resources
Berlin 2001
Wednesday 26.09.2001
Interstitial lung disease: BAL in diagnosis and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
M. W. Ziegenhagen, M. Rothe, M. Schlaak, J. Müller-Quernheim (Borstel, Germany)
Source:
Annual Congress 2001 - Interstitial lung disease: BAL in diagnosis and management
Session:
Interstitial lung disease: BAL in diagnosis and management
Session type:
Oral Presentation
Number:
3417
Disease area:
Interstitial lung diseases
Abstract
The aim of this study was to determine which of the BAL parameters do reflect the severity of newly diagnosed pulmonary sarcoidosis.
74 previously untreated patients with biopsy-proven, newly diagnosed sarcoidosis and 48 age-matched healthy controls were included in this study. Due to established clinical criteria, the sarcoid patients were divided into three groups: 10 patients with Löfgren's syndrome, 51 patients with stable disease and 13 patients with progressing disease in whom a systemic steroid therapy had to be initiated.
The total cell count, percentage of alveolar macrophages (AM) and lymphocytes, as well as the CD4/CD8-ratio were not associated with the severity of disease. Interestingly, we observed a significant increase of neutrophils (5.2 ±] 1.1 %; p = 0.0005 vs. controls) and eosinophils in sarcoid patients with progressing disease (1.7 ±] 0.6 %, p < 0.0005 vs. controls). An association between an elevated percentage of neutrophils in the BAL and the necessity for a systemic steroid therapy was not only observed in patients with an advanced sarcoidosis (radiological type III or IV) but also in sarcoid patients with earlier stages (radiological type I, II).
In conclusion, our results demonstrate that an increased percentage of neutrophils (> 3.0 %) and eosinophils (> 1.0 %) in the BALF of newly diagnosed sarcoid patients reflects the disease severity and may be helpful markers of a progressive disease.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. W. Ziegenhagen, M. Rothe, M. Schlaak, J. Müller-Quernheim (Borstel, Germany). Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?. Eur Respir J 2001; 16: Suppl. 31, 3417
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
Correlations between the bronchoalveolar lavage cytology and lung function stage in newly diagnosed sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 538s
Year: 2006
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003
Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Variations of the bronchoalveolar lavage cells populations with age in the newly diagnosed sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 743s
Year: 2006
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Concordance analysis of cells present in bronchoalveolar lavage in patients with interstitial lung diseases by type of readings and pulmonary location
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
The reflection of the ventilatory dysfunction by the bronchoalveolar lavage cytological pattern in newly diagnosed sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008
Comparison between induced sputum and bronchoalveolar lavage fluid for diagnosis of pulmonary tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Bronchoalveolar lavage differential cell count on assessment of patients with pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Comparison of induced sputum and bronchoalveolar lavage cell differential in patients with sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept